Bayer, Mitsui Chemicals Agro to develop novel parasiticides for petsJuly 9, 2018Bayer Animal Health GmbH and Mitsui Chemicals Agro Inc. (MCAG) have signed a global license agreement in which Bayer will develop novel companion animal parasiticide compounds based on MCAG's intellectual property. Further terms of the agreement were not disclosed. "At Bayer, we passionately care for the health and well-being of animals," said Dr. Dirk Ehle, head of Bayer Animal Health. "And we have long been committed to help …
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More